News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,722 Results
Type
Article (14480)
Company Profile (114)
Press Release (350128)
Section
Business (112744)
Career Advice (456)
Deals (18653)
Drug Delivery (28)
Drug Development (31348)
Employer Resources (50)
FDA (8814)
Job Trends (7715)
News (173077)
Policy (12397)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1328)
Allergies (39)
Alliances (34780)
ALS (22)
Alzheimer's disease (506)
Antibody-drug conjugate (ADC) (62)
Approvals (8834)
Artificial intelligence (227)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6565)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (109)
Cancer (951)
Cardiovascular disease (61)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (257)
Cervical cancer (10)
Clinical research (24555)
Collaboration (566)
Compensation (108)
Complete response letters (3)
COVID-19 (1161)
CRISPR (34)
C-suite (132)
Cystic fibrosis (48)
Data (912)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (93)
Diagnostics (4903)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (74)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38668)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51233)
Executive appointments (366)
FDA (9392)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (447)
Gene editing (80)
Generative AI (23)
Gene therapy (161)
GLP-1 (224)
Government (1241)
Grass and pollen (2)
Guidances (23)
Healthcare (9934)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (28)
Indications (11)
Infectious disease (1232)
Inflammatory bowel disease (60)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (51)
IPO (8036)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (116)
Leadership (3)
Legal (2521)
Liver cancer (34)
Lung cancer (121)
Lymphoma (56)
Machine learning (2)
Management (17)
Manufacturing (167)
MASH (15)
Medical device (11485)
Medtech (11490)
Mergers & acquisitions (10942)
Metabolic disorders (201)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (685)
NextGen: Class of 2025 (3539)
Non-profit (1519)
Northern California (1029)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (46)
Pancreatic cancer (38)
Parkinson's disease (63)
Partnered (11)
Patents (129)
Patient recruitment (48)
Peanut (26)
People (32696)
Pharmaceutical (16)
Phase I (9040)
Phase II (11084)
Phase III (7211)
Pipeline (499)
Podcasts (37)
Policy (27)
Postmarket research (502)
Preclinical (4085)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (134)
Real estate (3358)
Recruiting (20)
Regulatory (9366)
Reports (18)
Research institute (1274)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (2)
RSV (21)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1118)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2506)
State (2)
Stomach cancer (2)
Supply chain (22)
The Weekly (18)
United States (10887)
Vaccines (309)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (77)
Last 7 days (347)
Last 30 days (1403)
Last 365 days (17738)
2025 (4250)
2024 (18782)
2023 (22163)
2022 (30901)
2021 (32605)
2020 (30659)
2019 (25834)
2018 (19470)
2017 (18897)
2016 (17777)
2015 (20570)
2014 (15186)
2013 (12746)
2012 (13788)
2011 (14071)
2010 (12830)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (120)
Arkansas (10)
Asia (24009)
Australia (4181)
California (2692)
Canada (985)
China (228)
Colorado (154)
Connecticut (126)
Delaware (39)
Europe (49092)
Florida (455)
Georgia (131)
Idaho (33)
Illinois (265)
India (10)
Indiana (152)
Iowa (4)
Japan (100)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (433)
Massachusetts (1895)
Michigan (179)
Minnesota (240)
Mississippi (2)
Missouri (57)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (851)
New Mexico (16)
New York (805)
North Carolina (505)
North Dakota (7)
Northern California (1029)
Ohio (99)
Oklahoma (11)
Oregon (19)
Pennsylvania (593)
Puerto Rico (7)
Rhode Island (20)
South America (505)
South Carolina (16)
South Dakota (1)
Southern California (1118)
Tennessee (55)
Texas (437)
Utah (99)
Virginia (53)
Washington D.C. (11)
Washington State (311)
West Virginia (3)
Wisconsin (35)
364,722 Results for "alveo technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point-of-Need
February 26, 2025
·
5 min read
Biotech Bay
Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced the results of rigorous testing that demonstrate the ruggedness of its portable molecular testing platform.
June 18, 2024
·
3 min read
Press Releases
Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic
December 11, 2024
·
3 min read
Business
Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains
Alveo Technologies, Inc. announced a partnership with NYtor B.V, an innovative assay developer, to create a rapid, accurate, pen-side test that will detect the dominant swine flu strains, including H1N1, H1N2 and H3N2.
April 23, 2024
·
3 min read
Press Releases
Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU
November 1, 2024
·
4 min read
Biotech Bay
Alveo Technologies Announces Major Distribution Expansion Across EMEA
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced 19 new distributor partnerships across Europe, Africa, and the Middle East.
December 13, 2023
·
3 min read
Press Releases
Alveo Technologies Launches Academic Partnership Program to Drive Innovation in Point-of-Need Molecular Diagnostics with Global Virus Network as Inaugural Partner
September 27, 2024
·
5 min read
Biotech Bay
Alveo Technologies Is Developing Groundbreaking Avian Influenza Molecular Test for Poultry in Partnership with x-OvO, Royal GD, and Pharmsure
Alveo Technologies, Inc. announced it is working with experts and leaders in the poultry industry to launch a rapid, accurate, in-the-field multiplex panel to test for all relevant strains of avian influenza, initially focusing on Group A, H5, H7, and H9.
January 9, 2024
·
5 min read
Business
Alveo Technologies and Corteva Agriscience Collaborate to Advance Molecular Crop Disease Diagnostics and Improve Crop Yields
Alveo Technologies, Inc. announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.
October 24, 2023
·
5 min read
Biotech Bay
Alveo Technologies Announces ISO 13485:2016 Certification
Alveo Technologies, Inc. today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.
March 21, 2023
·
4 min read
1 of 36,473
Next
